Drug-Resistance Mechanisms in Vibrio Cholerae O1outbreak strain, Haiti, 2010

Emerging Infectious Diseases

Volumn 17, Issue 11, 2011, Pages 2151-2154

  Sjölund Karlsson, Maria ^a   Reimer, Aleisha ^b   Folster, Jason P ^c   Walker, Matthew ^b   Dahourou, Georges Anicet ^a   Batra, Dhwani Govil ^a   Martin, Irene ^b   Joyce, Kevin ^a   Parsons, Michele B ^a   Boncy, Jacques ^d   Whichard, Jean M ^a   Gilmour, Matthew W ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c Ihrc Inc   (United States)

^d Ministry of Public Health and Population   (Haïti)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FURAZOLIDONE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAFURAZOLE; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; GENE LOCATION; GENE MUTATION; HAITI; INDIA; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MECHANICS; NONHUMAN; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; VIBRIO CHOLERAE;

EID: 84930476798     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1711.110720     Document Type: Article

References (15)

1. Sack DA, Lyke C, McLaughlin C, Suwanvanichkij V. Antimicrobial resistance in shigellosis, cholera, and campylobacteriosis. Geneva: World Health Organization; 2001 [cited 2011 Mar 23].http://www.who.int/drugresistance/Antimicrobial_resistance_in_shigellosis_cholera_and_cam.pdf
2. World Health Organization. Global Task Force on Cholera Control. First steps for managing an outbreak of acute diarrhoea. Geneva: The Organization; 2004 [cited 2011 Mar 23]. http://whqlibdoc.who.int/hq/2010/WHO_CDS_CSR_NCS_2003.7_Rev.2_eng.pdf
3. Kitaoka M, Miyata ST, Unterweger D, Pukatzki S. Antibiotic resistance mechanisms of Vibrio cholerae. J Med Microbiol. 2011;60:397-407. doi:10.1099/jmm.0.023051-0
4. Wozniak RA, Fouts DE, Spagnoletti M, Colombo MM, Cec-carelli D, Garriss G, et al. Comparative ICE genomics: insights into the evolution of the SXT/R391 family of ICEs. PLoS Genet. 2009;5:e1000786. doi:10.1371/journal.pgen.1000786
5. Burrus V, Marrero J, Waldor MK. The current ICE age: biology and evolution of SXT-related integrating conjugative elements. Plasmid. 2006;55:173-83. doi:10.1016/j.plasmid.2006.01.001
6. Waldor MK, Tschape H, Mekalanos JJ. A new type of conjuga-tive transposon encodes resistance to sulfamethoxazole, trimetho-prim, and streptomycin in Vibrio cholerae O139. J Bacteriol. 1996;178:4157-65.
7. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline-second ed. M45-A2. Wayne (PA): The Institute; 2010 [cited 2011 Mar 23]. http://www.clsi.org/source/orders/free/m45-A2.pdf
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial suceptibility testing; twentieth informational supplement. Supplement M100-S20. Wayne (PA): The Institute; 2010 [cited 2011 Mar 23]. http://www.clsi.org/source/orders/free/m100-s20.pdf
9. Centers for Disease Control and Prevention. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): human isolates final report, 2008. Atlanta: The Centers; 2010.
10. Chen S, Zhao S, White DG, Schroeder CM, Lu R, Yang H, et al. Characterization of multiple-antimicrobial-resistant Salmonella serovars isolated from retail meats. Appl Environ Microbiol. 2004;70:1-7. doi:10.1128/AEM.70.1.1-7.2004
11. Reimer AR, Van Domselaar G, Stroika S, Walker M, Kent H, Tarr C, et al. Comparative genomics of Vibrio cholerae from Haiti, Asia, and Africa. Emerg Infect Dis. 2011;17:2113-21.
12. White DG, Hudson C, Maurer JJ, Ayers S, Zhao S, Lee MD, et al. Characterization of chloramphenicol and fl orfenicol resistance in Escherichia coli associated with bovine diarrhea. J Clin Microbiol. 2000;38:4593-8.
13. Chin CS, Sorenson J, Harris JB, Robins WP, Charles RC, Jean-Charles RR, et al. The origin of the Haitian cholera outbreak strain. N Engl J Med. 2011;364:33-42. doi:10.1056/NEJMoa1012928
14. Ceccarelli D, Spagnoletti M, Bacciu D, Danin-Poleg Y, Mendiratta DK, Kashi Y, et al. ICEVchInd5 is prevalent in epidemic Vibrio cholerae O1 El Tor strains isolated in India. Int J Med Microbiol. 2011;301:318-24. doi:10.1016/j.ijmm.2010.11.005
15. Dalsgaard A, Forslund A, Petersen A, Brown DJ, Dias F, Monteiro S, et al. Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic Vibrio cholerae O1 strains isolated in Guinea-Bissau. J Clin Microbiol. 2000;38:3774-9.